Yet another study has emerged to confirm that ivermectin can successfully treat cancer patients.
Researchers in Mexico have revealed that ivermectin outperforms chemotherapy as a treatment for breast cancer.
Scientists have been publishing research dating back to 1996 showing that ivermectin could be an effective cancer treatment.
More recent research has discovered that ivermectin inhibits cancer stem cells.
Tumor growth is generally driven by so-called bulk tumor cells.
However, another subpopulation of cells within cancer tumors presents a stem cell phenotype.
These cells are referred to in the scientific literature as “cancer stem-like cells” or CSCs.
What makes cancer stem-like cells such a threat is the fact that they keep reproducing endlessly.
These unlimited self-renewal properties allow many severe cancers to take over a person’s body.
In 2009, researchers from MIT and Harvard found that salinomycin, another antiparasitic drug, helps to reduce breast cancer stem cells by more than 100-fold compared to the chemotherapy drug paclitaxel (Taxol).
The research team found that salinomycin also inhibited the growth of breast tumors.
Scientists from Mexico City have built upon this earlier research in a more recent study by looking for the molecule most resembling salinomycin.
They analyzed 1,623 compounds and discovered that the one responsible for destroying cancer cells is ivermectin.
“Ivermectin preferentially inhibits the viability of cancer stem cell-enriched populations compared with the total cell population,” their research states.
“The opposite pattern was observed with paclitaxel treatment.”
According to the Mexican study, ivermectin prevents three different “stemness genes” from expressing themselves.
These stemness genes are highly expressed in cancer stem cells.
By inhibiting the cells’ expression, ivermectin blocks cancer tumors from growing and spreading.
In their conclusion, the Mexican scientists declared that ivermectin preferentially targets the stem cell population in MDA-MB-231 human breast cancer cells.
“Ivermectin has been demonstrated to be safe, following treatment of millions of patients with onchocerciasis and other parasitic diseases, which makes it a strong candidate for further studies investigating its potential use as a repurposed drug for cancer therapy,” the researchers note.
The researchers confirmed that ivermectin worked up to 100 times better than chemotherapy drugs but with no serious side effects.
The drug selectively targets the cancer stem cells that not only interfere with conventional cancer treatments but also drive metastasis and breast cancer recurrence.
Commenting on the findings, Dr. William Makis, M.D., a renowned oncologist, radiologist, and immunologist, said:
“Bottom line: Every advanced breast cancer patient should get ivermectin to eliminate cancer stem cells and reduce the risks of treatment failure, metastases, and recurrence.
“So why don’t they? I think we all know the answer.”
As Slay News recently reported, cancer patients have been leaving doctors stunned after making miraculous recoveries from taking ivermectin.
Dr. Makis revealed that one patient made an amazing recovery from stage 4 prostate cancer.
The patient said they have been secretly taking ivermectin along with other treatments and left their doctors stunned by recovering “quite quickly.”
They told Makik that they followed his protocol for ivermectin without telling their own doctor.
As a result, the patient saw his PSA scores fall to remission levels “quite quickly” after taking ivermectin.
Doctors were shocked to see “how quickly” the patient recovered with “no problem/side effects at all.”
Other leading oncology experts are also coming forward with similar stories of miraculous recoveries after ivermectin treatments.
As Slay News previously reported, renowned surgical oncologist Dr. Kathleen Ruddy has seen several late-stage cancer patients make dramatic recoveries after taking ivermectin.
Ruddy said several other patients have also been treated with ivermectin and they all made miraculous recoveries.
After witnessing the results, Ruddy said she needed to raise the alert about the success of the drug.
“I was as astonished as anyone might be that ivermectin has potential as an anti-cancer agent,” says Ruddy.
She noted that the probably of the patients recovering coincidentally while taking ivermectin was “zero”
“It’s like winning the lottery on the first three tickets you ever buy,” she explained.
WATCH: Click on the 'text' at the top of the video block to view...
No comments:
Post a Comment